• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

    4.885 +0.165 (+3.50%)
    Streaming Delayed Price Updated: 3:13 PM EDT, Oct 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 775,077
    Open 4.810
    Bid (Size) 4.870 (4)
    Ask (Size) 4.900 (7)
    Prev. Close 4.720
    Today's Range 4.725 - 5.090
    52wk Range 3.710 - 11.00
    Shares Outstanding 14,508,063
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    Important Notice to Long-Term Shareholders of CS Disco Inc. (NYSE: LAW); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire

    Performance

    YTD
    -38.4%
    -38.4%
    1 Month
    +17.7%
    +17.7%
    3 Month
    +10.5%
    +10.5%
    6 Month
    -24.1%
    -24.1%
    1 Year
    -2.1%
    -2.1%

    More News

    Read More
    UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
    From Faruqi & Faruqi, LLP
    Via Business Wire
    UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Unicycive to Contact the Firm Before the October 14th Deadline in the Filed Class Action Lawsuit
    From Bragar Eagel & Squire
    Via GlobeNewswire
    UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
    Via NewMediaWire
    Topics Fraud Lawsuit
    Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
    Via TheNewswire.com
    Topics Fraud Lawsuit
    UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges Investor to Contact the Firm Before the October 14th Deadline
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) Shareholders
    Via NewMediaWire
    Topics Fraud Lawsuit
    Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) Shareholders
    Via TheNewswire.com
    Topics Fraud Lawsuit
    UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    Important Notice to Long-Term Shareholders of Humana Inc. (NYSE: HUM); Jasper Therapeutics, Inc. (NASDAQ: JSPR); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf
    From Grabar Law Office
    Via GlobeNewswire
    UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the October 14th Deadline in the Unicycive Class Action Lawsuit
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - UNCY
    Via NewMediaWire
    Topics Fraud Lawsuit
    Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - UNCY
    Via TheNewswire.com
    Topics Fraud Lawsuit
    UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY
    From The Rosen Law Firm PA
    Via GlobeNewswire
    UNICYCIVE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Unicycive to Contact the Firm Regarding Filed Class Action Lawsuit Before October 14th
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Levi & Korsinsky Notifies Shareholders of Unicycive Therapeutics, Inc. (UNCY) of a Class Action Lawsuit and an Upcoming Deadline
    Via NewMediaWire
    Topics Fraud Lawsuit
    Levi & Korsinsky Notifies Shareholders of Unicycive Therapeutics, Inc. (UNCY) of a Class Action Lawsuit and an Upcoming Deadline
    Via TheNewswire.com
    Topics Fraud Lawsuit
    Investors Who Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCY
    Via NewMediaWire
    Topics Fraud Lawsuit
    Investors Who Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCY
    Via TheNewswire.com
    Topics Fraud Lawsuit
    ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY
    From The Rosen Law Firm PA
    Via GlobeNewswire

    Frequently Asked Questions

    Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
    Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
    The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
    What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
    The current price of Unicycive Therapeutics, Inc. - Common Stock is 4.885
    When was Unicycive Therapeutics, Inc. - Common Stock last traded?
    The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 10/29/25 03:13 PM ET
    What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
    The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 70.87M
    How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
    Unicycive Therapeutics, Inc. - Common Stock has 71M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.